Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia
Background: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motiva...
| 發表在: | Life |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
MDPI AG
2025-10-01
|
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2075-1729/15/10/1537 |
| _version_ | 1848667987388661760 |
|---|---|
| author | Elena Vakonaki Iordanis Pelagiadis Stella Baliou Manolis N. Tzatzarakis Athanasios Alegakis Ioanna Lygerou Persefoni Fragkiadaki Maria Stratigaki Nikolaos Katzilakis Aristidis Tsatsakis Eftichia Stiakaki |
| author_facet | Elena Vakonaki Iordanis Pelagiadis Stella Baliou Manolis N. Tzatzarakis Athanasios Alegakis Ioanna Lygerou Persefoni Fragkiadaki Maria Stratigaki Nikolaos Katzilakis Aristidis Tsatsakis Eftichia Stiakaki |
| author_sort | Elena Vakonaki |
| collection | DOAJ |
| container_title | Life |
| description | Background: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motivated us to examine telomere length values in children with ALL at the time of diagnosis and after treatment using quantitative polymerase chain reaction (qPCR) (<i>n</i> = 35). To achieve high-resolution precision and cell specificity, a quantitative fluorescence in situ hybridization (qFISH) technique was developed (<i>n</i> = 5). Results: The results demonstrated statistically significant evidence of telomere shortening in the lymphoblasts of children with ALL but not in the lymphocytes of children after remission following treatment. Our findings also suggested a significant association between telomere shortening and a high risk of relapse disease. Last but not least, our preliminary results showed a trend that telomere shortening was more pronounced in children with B-ALL compared to those with T-ALL in a non-significant manner. Conclusions: Consequently, the current study provides preliminary insights into the potentially substantial prognostic value of telomere length in the progression of pediatric ALL, with the possibility of predicting treatment response. To clarify the application of telomere length as a possible biomarker for disease progression and treatment response in children with ALL, the telomere length values of additional participants need to be examined in further studies. |
| format | Article |
| id | doaj-art-e2e11aef6d4f43c288dcaeaca1f1e40d |
| institution | Directory of Open Access Journals |
| issn | 2075-1729 |
| language | English |
| publishDate | 2025-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| spelling | doaj-art-e2e11aef6d4f43c288dcaeaca1f1e40d2025-10-28T16:48:40ZengMDPI AGLife2075-17292025-10-011510153710.3390/life15101537Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic LeukemiaElena Vakonaki0Iordanis Pelagiadis1Stella Baliou2Manolis N. Tzatzarakis3Athanasios Alegakis4Ioanna Lygerou5Persefoni Fragkiadaki6Maria Stratigaki7Nikolaos Katzilakis8Aristidis Tsatsakis9Eftichia Stiakaki10Laboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceDepartment of Pediatric Hematology-Oncology and Autologous Hematopoietic Stem Cell Transplanta-tion Unit, University Hospital of Heraklion and Laboratory of Blood Diseases and Childhood Cancer Bi-ology, School of Medicine, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, GreeceMSc Program “Hematology-Oncology of Childhood and Adolescence”, School of Medicine, University of Crete, 71003 Heraklion, GreeceBackground: Although telomere length maintenance is a common characteristic of hematological malignancies, the role of telomere length as a prognostic factor to stratify acute lymphoblastic leukemia (ALL) patients depending on their risk of relapse remains elusive. Methods: This knowledge gap motivated us to examine telomere length values in children with ALL at the time of diagnosis and after treatment using quantitative polymerase chain reaction (qPCR) (<i>n</i> = 35). To achieve high-resolution precision and cell specificity, a quantitative fluorescence in situ hybridization (qFISH) technique was developed (<i>n</i> = 5). Results: The results demonstrated statistically significant evidence of telomere shortening in the lymphoblasts of children with ALL but not in the lymphocytes of children after remission following treatment. Our findings also suggested a significant association between telomere shortening and a high risk of relapse disease. Last but not least, our preliminary results showed a trend that telomere shortening was more pronounced in children with B-ALL compared to those with T-ALL in a non-significant manner. Conclusions: Consequently, the current study provides preliminary insights into the potentially substantial prognostic value of telomere length in the progression of pediatric ALL, with the possibility of predicting treatment response. To clarify the application of telomere length as a possible biomarker for disease progression and treatment response in children with ALL, the telomere length values of additional participants need to be examined in further studies.https://www.mdpi.com/2075-1729/15/10/1537acute lymphoblastic leukemia (ALL)childhoodtelomere length |
| spellingShingle | Elena Vakonaki Iordanis Pelagiadis Stella Baliou Manolis N. Tzatzarakis Athanasios Alegakis Ioanna Lygerou Persefoni Fragkiadaki Maria Stratigaki Nikolaos Katzilakis Aristidis Tsatsakis Eftichia Stiakaki Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia acute lymphoblastic leukemia (ALL) childhood telomere length |
| title | Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia |
| title_full | Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia |
| title_fullStr | Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia |
| title_full_unstemmed | Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia |
| title_short | Insights into the Prognostic Value of Telomere Length in Childhood Acute Lymphoblastic Leukemia |
| title_sort | insights into the prognostic value of telomere length in childhood acute lymphoblastic leukemia |
| topic | acute lymphoblastic leukemia (ALL) childhood telomere length |
| url | https://www.mdpi.com/2075-1729/15/10/1537 |
| work_keys_str_mv | AT elenavakonaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT iordanispelagiadis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT stellabaliou insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT manolisntzatzarakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT athanasiosalegakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT ioannalygerou insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT persefonifragkiadaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT mariastratigaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT nikolaoskatzilakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT aristidistsatsakis insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia AT eftichiastiakaki insightsintotheprognosticvalueoftelomerelengthinchildhoodacutelymphoblasticleukemia |
